A7A Fundamental Analysis - HELIAD AG

Fundamental Rating

Overall A7A gets a fundamental rating of 3 out of 10. We evaluated A7A against 112 industry peers in the Capital Markets industry. There are concerns on the financial health of A7A while its profitability can be described as average. A7A has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year A7A was profitable.

In multiple years A7A reported negative net income over the last 5 years.

In the past 5 years A7A reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of A7A (2.82%) is better than 66.96% of its industry peers.

Looking at the Return On Equity, with a value of 3.59%, A7A is in line with its industry, outperforming 45.54% of the companies in the same industry.

With a Return On Invested Capital value of 1.67%, A7A perfoms like the industry average, outperforming 59.82% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	2.82%
ROE	3.59%
ROIC	1.67%

ROA(3y)-3.65%

ROA(5y)-2.19%

ROE(3y)-4.7%

ROE(5y)-2.82%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

A7A's Profit Margin of 519.85% is amongst the best of the industry. A7A outperforms 98.21% of its industry peers.

In the last couple of years the Profit Margin of A7A has declined.

Looking at the Operating Margin, with a value of 431.95%, A7A belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

In the last couple of years the Operating Margin of A7A has grown nicely.

Looking at the Gross Margin, with a value of 93.38%, A7A belongs to the top of the industry, outperforming 91.07% of the companies in the same industry.

In the last couple of years the Gross Margin of A7A has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	431.95%
PM (TTM)	519.85%
GM	93.38%

OM growth 3Y132.69%

OM growth 5Y55.14%

PM growth 3YN/A

PM growth 5Y-11.53%

GM growth 3Y-0.25%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, A7A has about the same amount of shares outstanding.

The number of shares outstanding for A7A has been increased compared to 5 years ago.

A7A has a worse debt/assets ratio than last year.

2.2 Solvency

A7A has an Altman-Z score of 4.43. This indicates that A7A is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 4.43, A7A belongs to the top of the industry, outperforming 84.82% of the companies in the same industry.

A Debt/Equity ratio of 0.24 indicates that A7A is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.24, A7A is doing good in the industry, outperforming 67.86% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.24
Debt/FCF	N/A
Altman-Z	4.43

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A7A has a Current Ratio of 0.57. This is a bad value and indicates that A7A is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of A7A (0.57) is comparable to the rest of the industry.

A7A has a Quick Ratio of 0.57. This is a bad value and indicates that A7A is not financially healthy enough and could expect problems in meeting its short term obligations.

A7A has a Quick ratio of 0.57. This is comparable to the rest of the industry: A7A outperforms 50.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.57
Quick Ratio	0.57

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 114.16% over the past year.

The earnings per share for A7A have been decreasing by -46.21% on average. This is quite bad

Looking at the last year, A7A shows a very negative growth in Revenue. The Revenue has decreased by -40.16% in the last year.

The Revenue for A7A have been decreasing by -33.67% on average. This is quite bad

EPS 1Y (TTM)114.16%

EPS 3YN/A

EPS 5Y-46.21%

EPS Q2Q%144.44%

Revenue 1Y (TTM)-40.16%

Revenue growth 3Y-52.27%

Revenue growth 5Y-33.67%

Sales Q2Q%611.32%

3.2 Future

Based on estimates for the next years, A7A will show a very strong growth in Earnings Per Share. The EPS will grow by 30.71% on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y200%

EPS Next 2Y73.21%

EPS Next 3Y44.23%

EPS Next 5Y30.71%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 43.94, which means the current valuation is very expensive for A7A.

A7A's Price/Earnings ratio is in line with the industry average.

A7A's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.06.

Based on the Price/Forward Earnings ratio of 23.93, the valuation of A7A can be described as rather expensive.

60.71% of the companies in the same industry are more expensive than A7A, based on the Price/Forward Earnings ratio.

The average S&P500 Price/Forward Earnings ratio is at 22.69. A7A is around the same levels.

		Industry Rank	Sector Rank
PE	43.94
Fwd PE	23.93

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A7A's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A7A's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.

PEG (NY)0.22

PEG (5Y)N/A

EPS Next 2Y73.21%

EPS Next 3Y44.23%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for A7A!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HELIAD AG

FRA:A7A (9/5/2025, 7:00:00 PM)

14.5

0 (0%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)04-30 2025-04-30

Earnings (Next)09-29 2025-09-29

Inst Owners0.79%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap121.94M

Analysts80

Price Target24.68 (70.21%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)56.13%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)200%

EPS NY rev (3m)200%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	43.94
Fwd PE	23.93
P/S	230.52
P/FCF	N/A
P/OCF	N/A
P/B	1.59
P/tB	1.59
EV/EBITDA	N/A

EPS(TTM)0.33

EY2.28%

EPS(NY)0.61

Fwd EY4.18%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS0.06

BVpS9.11

TBVpS9.1

PEG (NY)0.22

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	2.82%
ROE	3.59%
ROCE	2.93%
ROIC	1.67%
ROICexc	1.79%
ROICexgc	1.79%
OM	431.95%
PM (TTM)	519.85%
GM	93.38%
FCFM	N/A

ROA(3y)-3.65%

ROA(5y)-2.19%

ROE(3y)-4.7%

ROE(5y)-2.82%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y-8.62%

ROICexcg growth 5Y12.14%

ROICexc growth 3Y-8.62%

ROICexc growth 5Y12.14%

OM growth 3Y132.69%

OM growth 5Y55.14%

PM growth 3YN/A

PM growth 5Y-11.53%

GM growth 3Y-0.25%

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.01

Health

		Industry Rank	Sector Rank
Debt/Equity	0.24
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.57
Quick Ratio	0.57
Altman-Z	4.43

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)114.16%

EPS 3YN/A

EPS 5Y-46.21%

EPS Q2Q%144.44%

EPS Next Y200%

EPS Next 2Y73.21%

EPS Next 3Y44.23%

EPS Next 5Y30.71%

Revenue 1Y (TTM)-40.16%

Revenue growth 3Y-52.27%

Revenue growth 5Y-33.67%

Sales Q2Q%611.32%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y454.81%

EBIT growth 3Y11.06%

EBIT growth 5Y2.9%

EBIT Next Year-100%

EBIT Next 3Y22.99%

EBIT Next 5Y16.62%

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

HELIAD AG (A7A.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens